Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

High Dimensional Mass Cytometry as a Tool to Understand Ozanimod's Mechanism of Action (MOA)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06311123
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:53.750280+00:00
Published At
2024-03-15T00:00:00+00:00
Record Updated At
2024-03-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ulcerative Colitis", "Ulcerative Colitis Chronic Moderate"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-03-15"
protocolSection.identificationModule.nctId
"NCT06311123"
protocolSection.identificationModule.officialTitle
"High Dimensional Mass Cytometry as a Tool to Understand Ozanimod\u0027s Mechanism of Action (MOA)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ulcerative Colitis (protocolSection.conditionsModule.conditions)
  • Ulcerative Colitis Chronic Moderate (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.